Lovotibeglogene Autotemcel

CAS null 1 FDA-DMF supplierBiologic

Overview

Lovotibeglogene Autotemcel is a gene therapy product developed for the treatment of hemoglobin disorders such as sickle cell disease. It involves the ex vivo modification of a patient's hematopoietic stem cells to produce functional hemoglobin.

Therapeutic areas

Hematology

Related APIs

Rivaroxaban
57 suppliers
Apixaban
51 suppliers
Clopidogrel
40 suppliers
Deferasirox
24 suppliers
Azacitidine
21 suppliers
Lenalidomide
20 suppliers
Pentoxifylline
16 suppliers
Ibrutinib
16 suppliers

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo